| 2025-01-28 19-26-35 | Lumbar Spine T scores for Bone Mineral Density (BMD) may be normal or higher than normal in patients with Hypophosphatasia |
| 2025-01-28 18-56-43 | Bone Mineral Density (BMD) is generally high in patients with Hypoparathyroidism |
| 2025-01-22 12-28-31 | Increased Bone Mineral Density (BMD) in the lumbar spine of patients with Hypophosphatasia is associated with increased risk of fracture |
| 2025-01-22 12-33-11 | Bone Mineral Density (BMD) of the femoral neck is not associated with Alkaline Phosphatase (ALP) levels in patients with Hypophosphatasia |
| 2025-01-22 12-26-56 | Increased levels of Pyridoxal 5'-Phosphate (PLP, Vitamin B6) and Phosphoethanolamine (PEA) are associated with increased Bone Mineral Density (BMD) in the lumbar spine of patients with Hypophosphatasia |
| 2025-01-22 12-25-51 | Lower levels of serum Alkaline Phosphatase (ALP) are associated with increased Bone Mineral Density (BMD) in the Lumbar Spine in patients with Hypophosphatasia |